AKT1 and Hyperglycemia: Therefore, understanding the consequences of localized inhibition in vivo as reported in this study might help to determine a dose of the inhibitor that could be effective without the side-effects, in particular diarrhea, hyperglycaemia and liver injuries, which have been observed in previous clinical trials of AKT inhibitors60–62.